🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A single-centre Phase 1b study to assess the safety, tolerability, pharmaco...
Status
Completed
Location
Q-Pharm
Start Date
2018-04-23
Trial ID
NCT03542149
Intermittent preventive treatment (IPT) offers a way of preventing malaria ...
Status
Completed
Location
Medical Research Council Laboratories,
Start Date
2007-08
Trial ID
NCT00561899
Treatments Being Tested
This will be a single-centre, 5-cohort, randomized open-label, parallel-gro...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-07-31
Trial ID
NCT02184637
Treatments Being Tested
The study was designed to assess the effect of food on the extent and rate ...
Status
Completed
Location
CMAX, a division of IDT Australia Limited
Start Date
2010-03
Trial ID
NCT01222962
Treatments Being Tested
This is a single-centre, 2-part, randomised, single-dose parallel group stu...
Status
Completed
Location
Quotient Clinical
Start Date
2015-04
Trial ID
NCT02387580
Treatments Being Tested
WHO recommends the use of artemisinin-based combination therapies (ACTs) in...
Status
Unknown
Location
Nouna Research Centre
Start Date
2013-09
Trial ID
NCT02199951
Treatments Being Tested
Tafenoquine (TQ) is an 8-aminoquinoline anti-malarial drug which is in deve...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-04-08
Trial ID
NCT02802501
The Study was designed to evaluate the pharmacokinetics of DHA and PQ in he...
Status
Completed
Location
CMAX, a division of IDT Australia Limited
Start Date
2010-02
Trial ID
NCT01222949
Treatments Being Tested
The observed changes of P. falciparum sensitivity to artemisinin leads to t...
Status
Completed
Location
Hospital of Tropical Diseases, Faculty of Tropical Medicine, Mahidol University
Start Date
2012-06
Trial ID
NCT01525511
Sulfadoxine-pyrimethamine (SP) is currently recommended by the World Health...
Status
Completed
Location
Handeni District Hospital
Start Date
2016-09
Trial ID
NCT02909712
Treatments Being Tested